AMGN
Price
$414.87
Change
+$7.43 (+1.82%)
Updated
Oct 9 closing price
Capitalization
226.05B
24 days until earnings call
Intraday BUY SELL Signals
GILD
Price
$151.17
Change
+$4.07 (+2.77%)
Updated
Oct 9 closing price
Capitalization
188.73B
12 days until earnings call
Intraday BUY SELL Signals
MRK
Price
$145.60
Change
+$3.22 (+2.26%)
Updated
Oct 9 closing price
Capitalization
366.84B
19 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AMGN or GILD or MRK

AMGN vs GILD vs MRK Comparison Chart in %
View a ticker or compare two or three
Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
AMGN vs GILD vs MRK: Fundamental Ratings
AMGN
GILD
MRK
OUTLOOK RATING
1..100
858176
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
9
Undervalued
11
Undervalued
PROFIT vs RISK RATING
1..100
81129
SMR RATING
1..100
149679
PRICE GROWTH RATING
1..100
223139
P/E GROWTH RATING
1..100
27712
SEASONALITY SCORE
1..100
851350

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMGN's Valuation (8) in the Biotechnology industry is in the same range as GILD (9) in the Biotechnology industry, and is in the same range as MRK (11) in the Pharmaceuticals Major industry. This means that AMGN's stock grew similarly to GILD’s and similarly to MRK’s over the last 12 months.

AMGN's Profit vs Risk Rating (8) in the Biotechnology industry is in the same range as GILD (11) in the Biotechnology industry, and is in the same range as MRK (29) in the Pharmaceuticals Major industry. This means that AMGN's stock grew similarly to GILD’s and similarly to MRK’s over the last 12 months.

AMGN's SMR Rating (14) in the Biotechnology industry is somewhat better than the same rating for MRK (79) in the Pharmaceuticals Major industry, and is significantly better than the same rating for GILD (96) in the Biotechnology industry. This means that AMGN's stock grew somewhat faster than MRK’s and significantly faster than GILD’s over the last 12 months.

AMGN's Price Growth Rating (22) in the Biotechnology industry is in the same range as GILD (31) in the Biotechnology industry, and is in the same range as MRK (39) in the Pharmaceuticals Major industry. This means that AMGN's stock grew similarly to GILD’s and similarly to MRK’s over the last 12 months.

MRK's P/E Growth Rating (2) in the Pharmaceuticals Major industry is in the same range as AMGN (27) in the Biotechnology industry, and is significantly better than the same rating for GILD (71) in the Biotechnology industry. This means that MRK's stock grew similarly to AMGN’s and significantly faster than GILD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMGNGILDMRK
RSI
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 4 days ago
61%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
55%
Bullish Trend 1 day ago
62%
Bullish Trend 1 day ago
65%
Momentum
ODDS (%)
Bullish Trend 1 day ago
61%
Bullish Trend 1 day ago
61%
Bearish Trend 1 day ago
55%
MACD
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
48%
Bearish Trend 4 days ago
56%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
42%
Advances
ODDS (%)
Bullish Trend 12 days ago
61%
Bullish Trend 1 day ago
64%
Bullish Trend 4 days ago
57%
Declines
ODDS (%)
Bearish Trend 5 days ago
47%
Bearish Trend 5 days ago
48%
Bearish Trend 10 days ago
51%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 1 day ago
70%
Bullish Trend 1 day ago
63%
Aroon
ODDS (%)
Bearish Trend 1 day ago
52%
Bullish Trend 1 day ago
60%
Bullish Trend 5 days ago
62%
COMPARISON
Comparison
Oct 10, 2026
Stock price -- (AMGN: $414.87, GILD: $151.17, MRK: $145.60)
Brand notoriety: AMGN, GILD and MRK are all notable
The three companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: AMGN: 65%, GILD: 81%, MRK: 81%
Market capitalization -- AMGN: $226.05B, GILD: $188.73B, MRK: $366.84B
$AMGN is valued at $226.05B, while GILD has a market capitalization of $188.73B, and MRK's market capitalization is $366.84B. The market cap for tickers in this @Pharmaceuticals: Major ranges from $4.8K to $1.06T. The average market capitalization across the @Pharmaceuticals: Major industry is $200.13B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMGN’s FA Score shows that 5 FA rating(s) are green while GILD’s FA Score has 3 green FA rating(s), and MRK’s FA Score reflects 3 green FA rating(s).

  • AMGN’s FA Score: 5 green, 0 red.
  • GILD’s FA Score: 3 green, 2 red.
  • MRK’s FA Score: 3 green, 2 red.
According to our system of comparison, AMGN is a better buy in the long-term than MRK, which in turn is a better option than GILD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMGN’s TA Score shows that 8 TA indicator(s) are bullish while GILD’s TA Score has 5 bullish TA indicator(s), and MRK’s TA Score reflects 5 bullish TA indicator(s).

  • AMGN’s TA Score: 8 bullish, 2 bearish.
  • GILD’s TA Score: 5 bullish, 3 bearish.
  • MRK’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, AMGN is a better buy in the short-term than GILD, which in turn is a better option than MRK.

Price Growth

AMGN (@Pharmaceuticals: Major) experienced а +2.94% price change this week, while GILD (@Pharmaceuticals: Major) price change was +4.44% , and MRK (@Pharmaceuticals: Major) price fluctuated +0.90% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -2.53%. For the same industry, the average monthly price growth was -5.20%, and the average quarterly price growth was +5.33%.

Reported Earning Dates

AMGN is expected to report earnings on Nov 03, 2026.

GILD is expected to report earnings on Oct 22, 2026.

MRK is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-2.53% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

View a ticker or compare two or three
AMGN
Daily Signal:
Gain/Loss:
GILD
Daily Signal:
Gain/Loss:
MRK
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NU16.120.74
+4.81%
Nu Holdings Ltd
SST2.340.07
+3.08%
System1
CSTL34.420.71
+2.11%
Castle Biosciences
HRB44.05-0.54
-1.21%
H&R Block
ALMU11.40-0.53
-4.44%
AELUMA INC

AMGN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMGN has been loosely correlated with PFE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if AMGN jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMGN
1D Price
Change %
AMGN100%
+1.82%
PFE - AMGN
51%
Loosely correlated
+1.65%
GILD - AMGN
48%
Loosely correlated
+2.77%
ABBV - AMGN
48%
Loosely correlated
+1.49%
BIIB - AMGN
47%
Loosely correlated
+3.33%
MRK - AMGN
47%
Loosely correlated
+2.26%
More